Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era

Vaccine

Volumn 29, Issue 49, 2011, Pages 9123-9126

  Kendall, Brian A ^a   Dascomb, Kristin K ^a,b   Mehta, Rajesh R ^b   Mason, Edward O ^c   Ampofo, Krow ^a   Pombo, David J ^a,b   Pavia, Andrew T ^a   Byington, Carrie L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INTERMOUNTAIN HEALTHCARE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bacteremia; Invasive pneumococcal disease; Pneumonia; Serotype; Streptococcus pneumoniae

Indexed keywords

HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE 7; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; BACTERIUM ISOLATION; DISEASE SEVERITY; EMPYEMA; FEMALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE; INTUBATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; UTAH; VACCINATION; VACCINES, CONJUGATE; YOUNG ADULT;

EID: 82555165781     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.009     Document Type: Article

References (15)

1. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease, United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005, 54(September (36)):893-897.
2. Hicks L.A., Harrison L.H., Flannery B., Hadler J.L., Schaffner W., Craig A.S., et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007, 196(November (9)):1346-1354.
3. Byington C.L., Samore M.H., Stoddard G.J., Barlow S., Daly J., Korgenski K., et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 2005, 41(July (1)):21-29.
4. Bender J.M., Ampofo K., Korgenski K., Daly J., Pavia A.T., Mason E.O., et al. Pneumococcal necrotizing pneumonia in Utah: does serotype matter?. Clin Infect Dis 2008, 46(May (9)):1346-1352.
5. Byington C.L., Korgenski K., Daly J., Ampofo K., Pavia A., Mason E.O. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 2006, 25(March (3)):250-254.
6. Lalitha M.K., Thomas K., Kumar R.S., Steinhoff M.C. Serotyping of Streptococcus pneumoniae by coagglutination with 12 pooled antisera. J Clin Microbiol 1999, 37(January (1)):263-265.
7. Albrich W.C., Baughman W., Schmotzer B., Farley M.M. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine. Clin Infect Dis 2007, 44(June (12)):1569-1576.
8. Rueda A.M., Serpa J.A., Matloobi M., Mushtaq M., Musher D.M. The spectrum of invasive pneumococcal disease at an adult tertiary care hospital in the early 21st century. Medicine (Baltimore) 2010, 89(September (5)):331-336.
9. Byington C.L., Hulten K.G., Ampofo K., Sheng X., Pavia A.T., Blaschke A.J., et al. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol 2010, 48(February (2)):520-525.
10. Pilishvili T., Lexau C., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010, 201(January (1)):32-41.
11. Metlay J.P., Lautenbach E., Li Y., Shults J., Edelstein P.H. Exposure to children as a risk factor for bacteremic pneumococcal disease: changes in the post-conjugate vaccine era. Arch Intern Med 2010, 170(April (8)):725-731.
12. Poolman J., Borrow R. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines. Expert Rev Vaccines 2011, 10(March (3)):307-322.
13. Paradiso P.R. Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children. Clin Infect Dis 2011, 52(May (10)):1241-1247.
14. Centers for Disease Control and Prevention. Vaccines and Immunizations. Statistics and Surveillance. 2009; Available from: [cited April 28, 2011]. http://www.cdc.gov/vaccines/stats-surv/default.htm.
15. Long S.S. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine. Clin Infect Dis 2005, 41(July (1)):30-34.